在纪念中:庆祝约翰·R·本菲尔德博士 (1931-2025) 的生命
Mark B Orringer1, Nicholas T Kouchoukos2, William A Baumgartner3
1Cameron Haight Distinguished University Emeritus Professor of Thoracic Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan.
The Annals of thoracic surgery
|February 15, 2026
概括
约翰·本菲尔德博士通过领导主要组织,显著地推进了心胸外科手术. 他的工作扩大了胸部外科医生数据库协会,并促进了未来外科医生的专业发展.
科学领域:
- 心胸外科手术 心胸外科手术
- 手术专业组织 手术专业组织
背景情况:
- 约翰·本菲尔德博士是胸部外科医生协会的第30任主席.
- 他在主要的胸部外科组织中担任了重要的领导角色.
- 他的职业生涯的标志是对该领域的广泛贡献.
研究的目的:
- 为了突出约翰·本菲尔德博士的有影响力的职业生涯和领导力.
- 为了表彰他对心胸外科和专业发展的贡献.
主要方法:
- 审查本菲尔德博士的领导职位和举措.
- 对他对胸部外科医生数据库协会的影响的分析.
- 检查他在促进道德,专业精神和教育方面的作用.
主要成果:
- 在扩大胸部外科医生协会数据库方面发挥了重要作用.
- 在心胸外科手术中促进道德和专业精神.
- 为新兴领导者提供增强的教育和指导计划.
结论:
- 贝恩菲尔德博士的领导力显著影响了心胸外科的方向.
- 他的努力促进了手术数据库,专业标准和教育的进步.
- 他通过指导,在塑造职业未来方面发挥了关键作用.
相关概念视频
Life Histories
16.4K
Overview
16.4K
Biological Effects of Radiation
15.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.5K
Rous Sarcoma Virus (RSV) and Cancer
5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.2K
Drugs Acting on Autonomic Ganglia: Blockers
1.8K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.8K
Heart Failure Drugs: β-Blockers
2.9K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.9K


